RT Journal
A1 Pluta RM, Lynm C, Golub RM
T1 GUillain-barré syndrome
JF JAMA
JO JAMA
YR 2011
FD January 19
VO 305
IS 3
SP 319
OP 319
DO 10.1001/jama.305.3.319
UL http://dx.doi.org/10.1001/jama.305.3.319
AB 
Guillain-Barré syndrome  (GBS) is a rare autoimmune  neurological disease in which the body' immune system produces antibodies against its own nerves, resulting in damage to them. It is named after 2 French doctors who described this syndrome for the first time in 2 soldiers during World War I. Cases of GBS may develop after an infection (for example, an upper respiratory or gastrointestinal illness). It is thought that the body makes antibodies to protect itself against an invading bacterium or virus. However, certain bacteria and viruses have protein coverings that resemble some normal proteins on the sheath that wraps around nerves (myelin sheath). This can lead to the bodys immune system attacking ones own nerves. The swine flu vaccine used in 1976 was associated with several cases of Guillain-Barré syndrome. The new types of flu vaccines have not had such an 
effect.